During the past decade, Kashiwa City Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kashiwa City Hospital" are "Diabetes" (1 trials), "Diabetes Mellitus" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Endocrine System Diseases" (1 trials) and "Glucose Metabolism Disorders" (1 trials). Many other conditions were trialed in "Kashiwa City Hospital" in a lesser frequency.

Most popular intervention types in "Kashiwa City Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alpha-Glucosidase Inhibitors (α-GI)" (1 trials), "Biguanide (BG)" (1 trials), "Dulaglutide" (1 trials), "Glinides (GLN)" (1 trials) and "Insulin Degludec" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kashiwa City Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kashiwa City Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Kashiwa City Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kashiwa City Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".